What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary areas of investigation include Internal medicine, Rheumatoid arthritis, Arthritis, Immunology and Rheumatology.
Josef S. Smolen has researched Internal medicine in several fields, including Endocrinology, Surgery and Physical therapy.
His Rheumatoid arthritis research incorporates themes from Gastroenterology, Placebo, Infliximab and Chemotherapy.
The concepts of his Arthritis study are interwoven with issues in Inflammation, Osteoclast, Cartilage and Pathology.
His studies deal with areas such as Tumor necrosis factor alpha and Inflammatory arthritis as well as Osteoclast.
Josef S. Smolen interconnects Disease activity, Systemic lupus erythematosus and Rheumatoid factor in the investigation of issues within Rheumatology.
His most cited work include:
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial (2178 citations)
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis (1592 citations)
- Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. (1492 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Rheumatoid arthritis, Immunology, Arthritis and Rheumatology.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology and Surgery.
His Rheumatoid arthritis study integrates concerns from other disciplines, such as Tumor necrosis factor alpha, Infliximab, Disease, Clinical trial and Physical therapy.
His biological study spans a wide range of topics, including Rheumatism and Severity of illness.
His Arthritis research is multidisciplinary, relying on both Inflammation, Proinflammatory cytokine, Osteoclast and Pathology.
His Autoantibody research includes themes of Epitope, Lupus erythematosus, Autoimmune disease and Autoimmunity.
He most often published in these fields:
- Internal medicine (46.60%)
- Rheumatoid arthritis (41.06%)
- Immunology (38.30%)
What were the highlights of his more recent work (between 2011-2020)?
- Internal medicine (46.60%)
- Rheumatoid arthritis (41.06%)
- Arthritis (22.34%)
In recent papers he was focusing on the following fields of study:
Josef S. Smolen focuses on Internal medicine, Rheumatoid arthritis, Arthritis, Physical therapy and Disease activity.
In his study, which falls under the umbrella issue of Internal medicine, Placebo and Golimumab is strongly linked to Gastroenterology.
Rheumatoid arthritis is a subfield of Immunology that Josef S. Smolen investigates.
Josef S. Smolen has included themes like Psoriasis, Osteoclast and Pathology in his Arthritis study.
The Physical therapy study combines topics in areas such as Observational study, Quality of life, Intensive care medicine, Rheumatism and Disease.
As part of one scientific family, Josef S. Smolen deals mainly with the area of Disease activity, narrowing it down to issues related to the Phases of clinical research, and often Secukinumab and Minimal disease.
Between 2011 and 2020, his most popular works were:
- Baricitinib in Patients with Refractory Rheumatoid Arthritis (290 citations)
- Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases (95 citations)
- Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis (85 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Immune system
His main research concerns Rheumatoid arthritis, Physical therapy, Internal medicine, Rheumatology and Clinical trial.
His Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Disease activity, Severity of illness, Epidemiology and Arthritis.
The various areas that Josef S. Smolen examines in his Arthritis study include Proteoglycan and Etanercept.
His Internal medicine research integrates issues from Cross-sectional study and Surgery.
His Rheumatology study frequently draws connections to other fields, such as Placebo.
His work carried out in the field of Clinical trial brings together such families of science as Biosimilar, Systematic review, Immunology and Rheumatoid factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
